Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Cogent Biosciences Inc (COGT)

Cogent Biosciences Inc (COGT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 230,460
  • Shares Outstanding, K 38,410
  • Annual Sales, $ 7,870 K
  • Annual Income, $ -74,810 K
  • 60-Month Beta 3.06
  • Price/Sales 30.45
  • Price/Cash Flow N/A
  • Price/Book 1.84
Trade COGT with:

Options Overview

Details
  • Implied Volatility 87.23%
  • Historical Volatility 54.60%
  • IV Percentile 10%
  • IV Rank 44.82%
  • IV High 182.05% on 07/06/21
  • IV Low 10.21% on 07/02/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 0
  • Volume Avg (30-Day) 5
  • Put/Call OI Ratio 0.00
  • Today's Open Interest 93
  • Open Int (30-Day) 54

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.39
  • Number of Estimates 5
  • High Estimate -0.23
  • Low Estimate -0.57
  • Prior Year -0.96
  • Growth Rate Est. (year over year) +59.38%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.95 +0.84%
on 07/30/21
8.28 -27.54%
on 07/02/21
-2.11 (-26.02%)
since 06/30/21
3-Month
5.95 +0.84%
on 07/30/21
9.59 -37.43%
on 06/15/21
-2.69 (-30.96%)
since 04/30/21
52-Week
5.95 +0.84%
on 07/30/21
14.44 -58.45%
on 10/27/20
-4.60 (-43.40%)
since 07/30/20

Most Recent Stories

More News
Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021

and , July 27, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that...

COGT : 6.00 (-3.85%)
Cogent Biosciences to Present at Ladenburg Thalmann Virtual Healthcare Conference 2021

and , /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that , Chief Executive...

COGT : 6.00 (-3.85%)
Biometrics Market Report 2021-2026: Global Industry Key Players, Size, Share, Growth, Trends and Forecast

The post appeared first on .

COGT : 6.00 (-3.85%)
PSA.TO : 50.00 (unch)
Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021

and , /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced that , Chief Executive...

COGT : 6.00 (-3.85%)
Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results

and , /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for...

COGT : 6.00 (-3.85%)
Cogent Biosciences Appoints Evan Kearns as Chief Legal Officer

, Mass. and , /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the appointment...

COGT : 6.00 (-3.85%)
Cogent Biosciences Announces Creation of Cogent Research Team

, Colo. and , /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the formation...

COGT : 6.00 (-3.85%)
Cogent Biosciences, Inc. (COGT) Reports Q4 Loss, Lags Revenue Estimates

Cogent Biosciences, Inc. (COGT) delivered earnings and revenue surprises of -1910.00% and -100.00%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the...

COGT : 6.00 (-3.85%)
Cogent Biosciences Reports Fourth Quarter 2020 and Full Year 2020 Financial Results

, /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced financial results for the...

COGT : 6.00 (-3.85%)
Biometrics Market 2020-2025: Global Size, Share, Trends and Research Report

According to the latest report by IMARC Group, titled ": Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2020-25", the global biometrics market size reached US$ 19.84 Billion in 2019....

COGT : 6.00 (-3.85%)
PSA.TO : 50.00 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Cogent Biosciences Inc. is a biotechnology company. It is focused on developing precision therapies for genetically defined diseases. The company's program consist PLX9486. Cogent Biosciences Inc., formerly known as Unum Therapeutics Inc., is based in CAMBRIDGE, Mass.

See More

Key Turning Points

3rd Resistance Point 6.59
2nd Resistance Point 6.45
1st Resistance Point 6.23
Last Price 6.00
1st Support Level 5.86
2nd Support Level 5.72
3rd Support Level 5.50

See More

52-Week High 14.44
Fibonacci 61.8% 11.20
Fibonacci 50% 10.19
Fibonacci 38.2% 9.19
Last Price 6.00
52-Week Low 5.95

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar